Work

Semaglutide seems to be more effective the other GLP-1Ras

Year: 2017
Type: editorial
Abstract: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) were introduced as treatment options for type 2 diabetes (T2DM) in 2005 (1). They have become popular because of their efficacy and durability in relation to glycaemic control, and their low risk of hypoglycaemia in combination with weight loss in most patients (2,3).
Language: English
Field: Medicine
Open Access status: hybrid
OpenAlex ID: W2768268612
Cites: 35
Cited by: 52
Related to: 10